Page last updated: 2024-12-08

cholesterol acetate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

cholesteryl acetate : A cholesterol ester obtained by formal acylation of the hydroxy group of cholesterol by acetic acid. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID2723897
CHEMBL ID3138728
CHEBI ID78242
SCHEMBL ID25655
MeSH IDM0167118

Synonyms (55)

Synonym
cholest-5-en-3-ol (3beta)-, 3-acetate
ota9a3781t ,
unii-ota9a3781t
604-35-3
cholesteryl acetate
cholesterin acetate
cholesterol acetate
cholesteryl acetate, 97%
cholest-5-en-3-ol (3beta)-, acetate
3beta-acetoxycholest-5-ene
ccris 5350
einecs 210-066-4
cholest-5-en-3beta-ol acetate
cholest-5-en-3beta-yl acetate
ai3-24120
nsc 8799
acetyl cholesterol
LMST01010245
[(3s,8s,9s,10r,13r,14s,17r)-10,13-dimethyl-17-[(2r)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthren-3-yl] acetate
AKOS015955666
S10712
CHEMBL3138728
chebi:78242 ,
cholesterol 3.beta.-acetate
cholest-5-ene-3-ol (3.beta.)-, acetate
cholesteryl acetate [inci]
acetic acid, cholesterol ester
S4968
(-)-cholesteryl acetate
3-cholesteryl acetate
cholesterol 3-acetate
SCHEMBL25655
(3beta)-cholest-5-en-3-yl acetate
cholesterol 3beta-acetate
(3beta)-cholest-5-en-3-ol acetate
3b-acetoxycholest-5-ene
W-105252
cholesterylacetate
3a-cholesterol acetate
cholest-5-en-3-yl acetate #
cholesterol 3b-acetate
cholest-5-en-3b-ol acetate
(3b)-cholest-5-en-3-ol acetate
Q27147700
(3i(2))-cholest-5-en-3-yl ethanoate
cholest-5-en-3b-yl acetate
(3s,9s,10r,13r,14s,17r)-10,13-dimethyl-17-((r)-6-methylheptan-2-yl)-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-3-yl acetate
[(3s,8s,9s,10r,13r,14s,17r)-10,13-dimethyl-17-[(2r)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthren-3-yl]acetate
A868978
cholest-5-en-3-yl acetate; chloesteryl acetate; acetic acid cholesteryl ester; cholesterol acetate
DTXSID60889358
cholest-5-en-3-ol (3.beta.)-, 3-acetate
AS-57181
cholesterin acetate; cholesterol 3-acetate; cholesterol 3-acetate; cholesteryl acetate; nsc 8799
CS-0030699
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
human metaboliteAny mammalian metabolite produced during a metabolic reaction in humans (Homo sapiens).
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
cholesteryl esterA sterol ester obtained by formal condensation of the carboxy group of any carboxylic acid with the 3-hydroxy group of cholesterol.
acetate esterAny carboxylic ester where the carboxylic acid component is acetic acid.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (2)

Assay IDTitleYearJournalArticle
AID977599Inhibition of sodium fluorescein uptake in OATP1B1-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM2013Molecular pharmacology, Jun, Volume: 83, Issue:6
Structure-based identification of OATP1B1/3 inhibitors.
AID977602Inhibition of sodium fluorescein uptake in OATP1B3-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM2013Molecular pharmacology, Jun, Volume: 83, Issue:6
Structure-based identification of OATP1B1/3 inhibitors.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (34)

TimeframeStudies, This Drug (%)All Drugs %
pre-19903 (8.82)18.7374
1990's10 (29.41)18.2507
2000's14 (41.18)29.6817
2010's6 (17.65)24.3611
2020's1 (2.94)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other34 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]